A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
Since 2007, one-step nucleic acid amplification (OSNA) has been used as a diagnostic system for sentinel lymph node (SLN) examination in patients with breast cancer. This study aimed to define a new clinical cut-off of CK19 mRNA copy number based on the calculation of the risk that an axillary lymph...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171517&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850230618974060544 |
|---|---|
| author | Irene Terrenato Valerio D'Alicandro Beatrice Casini Letizia Perracchio Francesca Rollo Laura De Salvo Simona Di Filippo Franco Di Filippo Edoardo Pescarmona Marcello Maugeri-Saccà Marcella Mottolese Simonetta Buglioni Simonetta Buglioni |
| author_facet | Irene Terrenato Valerio D'Alicandro Beatrice Casini Letizia Perracchio Francesca Rollo Laura De Salvo Simona Di Filippo Franco Di Filippo Edoardo Pescarmona Marcello Maugeri-Saccà Marcella Mottolese Simonetta Buglioni Simonetta Buglioni |
| author_sort | Irene Terrenato |
| collection | DOAJ |
| description | Since 2007, one-step nucleic acid amplification (OSNA) has been used as a diagnostic system for sentinel lymph node (SLN) examination in patients with breast cancer. This study aimed to define a new clinical cut-off of CK19 mRNA copy number based on the calculation of the risk that an axillary lymph node dissection (ALND) will be positive. We analyzed 1529 SLNs from 1140 patients with the OSNA assay and 318 patients with positive SLNs for micrometastasis (250 copies) and macrometastasis (5000 copies) underwent ALND. Axillary non-SLNs were routinely examined. ROC curves and Youden's index were performed in order to identify a new cut-off value. Logistic regression models were performed in order to compare OSNA categorical variables created on the basis of our and traditional cut-off to better identify patients who really need an axillary dissection. 69% and 31% of OSNA positive patients had a negative and positive ALND, respectively. ROC analysis identified a cut-off of 2150 CK19 mRNA copies with 95% sensitivity and 51% specificity. Positive and negative predictive values of this new cut-off were 47% and 96%, respectively. Logistic regression models indicated that the cut-off of 2150 copies better discriminates patients with node negative or positive in comparison with the conventional OSNA cut-off (p<0.0001). This cut-off identifies false positive and false negative cases and true-positive and true negative cases very efficiently, and therefore better identifies which patients really need an ALND and which patients can avoid one. This is why we suggest that the negative cut-off should be raised from 250 to 2150. Furthermore, we propose that for patients with a copy number that ranges between 2150 and 5000, there should be a multidisciplinary discussion concerning the clinical and bio-morphological features of primary breast cancer before any decision is taken on whether to perform an ALND or not. |
| format | Article |
| id | doaj-art-aee28c9ebf7c48ddbdc1ed6217c6c059 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-aee28c9ebf7c48ddbdc1ed6217c6c0592025-08-20T02:03:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017151710.1371/journal.pone.0171517A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.Irene TerrenatoValerio D'AlicandroBeatrice CasiniLetizia PerracchioFrancesca RolloLaura De SalvoSimona Di FilippoFranco Di FilippoEdoardo PescarmonaMarcello Maugeri-SaccàMarcella MottoleseSimonetta BuglioniSimonetta BuglioniSince 2007, one-step nucleic acid amplification (OSNA) has been used as a diagnostic system for sentinel lymph node (SLN) examination in patients with breast cancer. This study aimed to define a new clinical cut-off of CK19 mRNA copy number based on the calculation of the risk that an axillary lymph node dissection (ALND) will be positive. We analyzed 1529 SLNs from 1140 patients with the OSNA assay and 318 patients with positive SLNs for micrometastasis (250 copies) and macrometastasis (5000 copies) underwent ALND. Axillary non-SLNs were routinely examined. ROC curves and Youden's index were performed in order to identify a new cut-off value. Logistic regression models were performed in order to compare OSNA categorical variables created on the basis of our and traditional cut-off to better identify patients who really need an axillary dissection. 69% and 31% of OSNA positive patients had a negative and positive ALND, respectively. ROC analysis identified a cut-off of 2150 CK19 mRNA copies with 95% sensitivity and 51% specificity. Positive and negative predictive values of this new cut-off were 47% and 96%, respectively. Logistic regression models indicated that the cut-off of 2150 copies better discriminates patients with node negative or positive in comparison with the conventional OSNA cut-off (p<0.0001). This cut-off identifies false positive and false negative cases and true-positive and true negative cases very efficiently, and therefore better identifies which patients really need an ALND and which patients can avoid one. This is why we suggest that the negative cut-off should be raised from 250 to 2150. Furthermore, we propose that for patients with a copy number that ranges between 2150 and 5000, there should be a multidisciplinary discussion concerning the clinical and bio-morphological features of primary breast cancer before any decision is taken on whether to perform an ALND or not.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171517&type=printable |
| spellingShingle | Irene Terrenato Valerio D'Alicandro Beatrice Casini Letizia Perracchio Francesca Rollo Laura De Salvo Simona Di Filippo Franco Di Filippo Edoardo Pescarmona Marcello Maugeri-Saccà Marcella Mottolese Simonetta Buglioni Simonetta Buglioni A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. PLoS ONE |
| title | A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. |
| title_full | A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. |
| title_fullStr | A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. |
| title_full_unstemmed | A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. |
| title_short | A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. |
| title_sort | cut off of 2150 cytokeratin 19 mrna copy number in sentinel lymph node may be a powerful predictor of non sentinel lymph node status in breast cancer patients |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171517&type=printable |
| work_keys_str_mv | AT ireneterrenato acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT valeriodalicandro acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT beatricecasini acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT letiziaperracchio acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT francescarollo acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT lauradesalvo acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonadifilippo acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT francodifilippo acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT edoardopescarmona acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT marcellomaugerisacca acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT marcellamottolese acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonettabuglioni acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonettabuglioni acutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT ireneterrenato cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT valeriodalicandro cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT beatricecasini cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT letiziaperracchio cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT francescarollo cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT lauradesalvo cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonadifilippo cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT francodifilippo cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT edoardopescarmona cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT marcellomaugerisacca cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT marcellamottolese cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonettabuglioni cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients AT simonettabuglioni cutoffof2150cytokeratin19mrnacopynumberinsentinellymphnodemaybeapowerfulpredictorofnonsentinellymphnodestatusinbreastcancerpatients |